1. Transcriptional regulation during myelopoiesis. Lenny N, Westendorf JJ, Hiebert SW (1997) Mol Biol Rep 24(3): 157-68
    › Primary publication · 9291089 (PubMed)
  2. Subcellular partitioning of transcription factors during osteoblast differentiation: developmental association of the AML/CBF alpha/PEBP2 alpha-related transcription factor-NMP-2 with the nuclear matrix. Lindenmuth DM, van Wijnen AJ, Hiebert S, Stein JL, Lian JB, Stein GS (1997) J Cell Biochem 66(1): 123-32
    › Primary publication · 9215534 (PubMed)
  3. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB (1997) J Cell Biochem 66(1): 1-8
    › Primary publication · 9215522 (PubMed)
  4. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW (1997) Proc Natl Acad Sci U S A 94(13): 6746-51
    › Primary publication · 9192636 (PubMed) · PMC21229 (PubMed Central)
  5. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW (1997) Mol Cell Biol 17(3): 1049-56
    › Primary publication · 9032231 (PubMed) · PMC231829 (PubMed Central)
  6. CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome. Legare RD, Lu D, Gallagher M, Ho C, Tan X, Barker G, Shimizu K, Ohki M, Lenny N, Hiebert S, Gilliland DG (1997) Leukemia 11(12): 2111-9
    › Primary publication · 9447828 (PubMed)
  7. Transcriptional regulation by the t(8;21) fusion protein, AML-1/ETO. Hiebert SW, Downing JR, Lenny N, Meyers S (1996) Curr Top Microbiol Immunol : 253-8
    › Primary publication · 8585956 (PubMed)
  8. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussell MF, Gilliland DG, Lenny N, Meyers S (1996) Mol Cell Biol 16(4): 1349-55
    › Primary publication · 8657108 (PubMed) · PMC231119 (PubMed Central)
  9. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Rhoades KL, Hetherington CJ, Rowley JD, Hiebert SW, Nucifora G, Tenen DG, Zhang DE (1996) Proc Natl Acad Sci U S A 93(21): 11895-900
    › Primary publication · 8876234 (PubMed) · PMC38155 (PubMed Central)
  10. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties. Zent C, Kim N, Hiebert S, Zhang DE, Tenen DG, Rowley JD, Nucifora G (1996) Curr Top Microbiol Immunol : 243-52
    › Primary publication · 8585955 (PubMed)